Rocío López‐Vacas

Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications

Angelo Gámez‐Pozo, Julia Berges‐Soria, Jorge M. Arevalillo et al. · Cancer Research · 2015 · 75 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

PTRF/Cavin-1 and MIF Proteins Are Identified as Non-Small Cell Lung Cancer Biomarkers by Label-Free Proteomics

Angelo Gámez‐Pozo, Iker Sánchez‐Navarro, Enrique Calvo et al. · PLoS ONE · 2012 · 73 citations · Full text

Life Sciences, Bioinformatics, Oncology +17

Functional proteomics outlines the complexity of breast cancer molecular subtypes

Angelo Gámez‐Pozo, Lucía Trilla‐Fuertes, Julia Berges‐Soria et al. · Scientific Reports · 2017 · 62 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses

Guillermo Prado-Vázquez, Angelo Gámez‐Pozo, Lucía Trilla‐Fuertes et al. · Scientific Reports · 2019 · 62 citations · Full text

Medicine, Bioinformatics, Oncology +17

Shotgun proteomics of archival triple‐negative breast cancer samples

Angelo Gámez‐Pozo, Nuria Ibarz Ferrer, Eva Ciruelos et al. · PROTEOMICS - CLINICAL APPLICATIONS · 2013 · 36 citations

Life Sciences, Molecular Biology, Oncology +17